Anthoula Koliadi

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort

Anthoula Koliadi, Cecilia Ahlin, Marit Holmqvist et al. · International Journal of Cancer · 2009 · 63 citations

Medicine, Oncology, Pathology +17

High proliferation is associated with inferior outcome in male breast cancer patients

Cecilia Nilsson, Anthoula Koliadi, Ida Johansson et al. · Modern Pathology · 2012 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +13

Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors

Antonios Valachis, Camilla Rosén, Anthoula Koliadi et al. · OncoImmunology · 2021 · 25 citations · Full text

Medicine, Immunology, Oncology +17

Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

Anthoula Koliadi, Cecilia Nilsson, Marit Holmqvist et al. · Acta Oncologica · 2010 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +16

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma

Bengt Tholander, Anthoula Koliadi, Johan Botling et al. · Upsala Journal of Medical Sciences · 2020 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17